Efficacy and safety of ferric citrate on hyperphosphatemia among Chinese patients with chronic kidney disease undergoing hemodialysis: a phase III multicenter randomized open-label active-drug controlled study.

Yong Wang, Xiangmei Chen, Hanyu Zhu,Zhiyong Guo,Yibin Yang,Ping Luo,Yani He,Yan Xu,Daxi Ji,Xinlu Gao,Xiuli Sun,Changying Xing,Yu Wang, Xiaohui Wang, Shuping Zhao,Yan Guan,Hongli Lin,Aimin Zhong,Hua Shui,Fengmin Shao, Lu Lv,Yuehong Yan, Xiaokun Sun,Lei Zhang

American journal of nephrology（2023）

引用 0|浏览32

暂无评分

摘要

Ferric citrate capsules have good efficacy and safety in the control of hyperphosphatemia in adult patients with CKD undergoing hemodialysis. Efficacy is not inferior to sevelamer carbonate. The TEAEs were mostly mild and tolerated by the patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要